MEVIS MEDSOL N
MEVIS MEDSOL N operates in Diversified Metals & Mining.
Market Cap & Net Worth: MEVIS MEDSOL N (M3V)
MEVIS MEDSOL N (MU:M3V) has a market capitalization of $259.78K (€253.08K) as of March 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #38779 globally and #5352 in its home market, demonstrating a 4.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEVIS MEDSOL N's stock price €26.00 by its total outstanding shares 9734 (9.73K).
MEVIS MEDSOL N Market Cap History: 2015 to 2026
MEVIS MEDSOL N's market capitalization history from 2015 to 2026. Data shows growth from $210.04K to $259.78K (2.76% CAGR).
MEVIS MEDSOL N Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEVIS MEDSOL N's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
MEVIS MEDSOL N's market cap is 0.01 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.05x
MEVIS MEDSOL N's market cap is 0.05 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $355.14K | $18.54 Million | $5.62 Million | 0.02x | 0.06x |
| 2018 | $280.45K | $16.76 Million | $7.17 Million | 0.02x | 0.04x |
| 2019 | $276.14K | $18.07 Million | $8.07 Million | 0.02x | 0.03x |
| 2020 | $299.19K | $17.13 Million | $5.70 Million | 0.02x | 0.05x |
| 2021 | $295.36K | $16.21 Million | $4.55 Million | 0.02x | 0.06x |
| 2022 | $335.63K | $18.76 Million | $7.79 Million | 0.02x | 0.04x |
| 2023 | $239.74K | $17.34 Million | $4.92 Million | 0.01x | 0.05x |
Competitor Companies of M3V by Market Capitalization
Companies near MEVIS MEDSOL N in the global market cap rankings as of March 19, 2026.
Key companies related to MEVIS MEDSOL N by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
MEVIS MEDSOL N Historical Marketcap From 2015 to 2026
Between 2015 and today, MEVIS MEDSOL N's market cap moved from $210.04K to $ 259.78K, with a yearly change of 2.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €259.78K | +5.69% |
| 2025 | €245.80K | -0.81% |
| 2024 | €247.79K | +3.36% |
| 2023 | €239.74K | -28.57% |
| 2022 | €335.63K | +13.64% |
| 2021 | €295.36K | -1.28% |
| 2020 | €299.19K | +8.35% |
| 2019 | €276.14K | -1.54% |
| 2018 | €280.45K | -21.03% |
| 2017 | €355.14K | +3.85% |
| 2016 | €341.97K | +62.81% |
| 2015 | €210.04K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MEVIS MEDSOL N was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $259.78K USD |
| MoneyControl | $259.78K USD |
| MarketWatch | $259.78K USD |
| marketcap.company | $259.78K USD |
| Reuters | $259.78K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.